highly significantp < 0.001
and HBV co-infection was 6% (95% CI 4–7%, Cochran's Q statistic < 0.001, I 2 : 95.8%), and there was highly significant heterogeneity (p < 0.001, I 2 : 95.8%) among the included studies (Fig. 2 ).
and HBV co-infection was 6% (95% CI 4–7%, Cochran's Q statistic < 0.001, I 2 : 95.8%), and there was highly significant heterogeneity (p < 0.001, I 2 : 95.8%) among the included studies (Fig. 2 ).